Stocks · Korea
318160
KOSDAQ
Cell Bio Human Tech
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
PER6.46x
PBR1.01x
EPS1,059 KRW
BPS6,775 KRW
ROE14.93%
Dividend yield0.00%
DPS0 KRW
Payout ratio0.00%
Returns and 52-week range
1W-6.56%
1M+6.05%
3M+14.19%
6M-3.12%
1Y-27.31%
YTD-20.19%
52W high11,200원
52W low4,960원
From 52W high-38.93%
Financial results (consolidated)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2023 | 273억 | 31억 | -19억 | 11.5% |
| 2024 | 284억 | 40억 | 44억 | 14.2% |
| 2025 | 511억 | 93억 | 87억 | 18.2% |
| Quarterly | ||||
| 2024 4Q | 83억 | 13억 | 20억 | 15.8% |
| 2025 1Q | 83억 | 15억 | 14억 | 17.7% |
| 2025 2Q | 140억 | 30억 | 16억 | 21.6% |
| 2025 3Q | 145억 | 36억 | 35억 | 24.9% |
| 2025 4Q | 143억 | 12억 | 22억 | 8.5% |
| 2026 1Q | 127억 | 15억 | 18억 | 11.4% |
Company
Address: 경기도 안양시 동안구 시민대로 401 대륭테크노타운15차 제2001호,제2101호
Peers in the same sector
Recent filings
- 2026-08-14반기보고서 (2026.06)
- 2026-06-10주요사항보고서(자기주식취득신탁계약체결결정) Major
- 2026-06-09주요사항보고서(자기주식취득신탁계약해지결정) Major
- 2026-05-14분기보고서 (2026.03)
Source: DART (Financial Supervisory Service electronic disclosure)
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.